Cornerstone Advisors’s CVS Health CVS Stock Holding History

Cornerstone Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,700	Closed	-$1.18M	–	189
2025 Q3	$1.18M	Sell	15,700 -18,100	-54%	-$1.24M	0.04%	198
2025 Q2	$2.33M	Buy	33,800 +4,500	+15%	+$295K	0.08%	167
2025 Q1	$1.99M	Hold	29,300	–	–	0.09%	178
2024 Q4	$1.32M	Buy	29,300 +2,100	+8%	+$118K	0.05%	204
2024 Q3	$1.71M	Hold	27,200	–	–	0.07%	199
2024 Q2	$1.61M	Sell	27,200 -800	-3%	-$50K	0.07%	201
2024 Q1	$2.23M	Hold	28,000	–	–	0.09%	203
2023 Q4	$2.21M	Sell	28,000 -5,800	-17%	-$413K	0.1%	199
2023 Q3	$2.36M	Buy	33,800 +18,400	+119%	+$1.3M	0.11%	184
2023 Q2	$1.06M	Buy	+15,400	New	+$1.1M	0.05%	205
2022 Q4	–	Sell	-155,000	Closed	-$14.8M	–	189
2022 Q3	$14.8M	Buy	155,000 +20,000	+15%	+$1.98M	0.73%	35
2022 Q2	$12.5M	Buy	135,000 +66,000	+96%	+$6.44M	0.66%	46
2022 Q1	$6.98M	Sell	69,000 -25,000	-27%	-$2.63M	0.41%	68
2021 Q4	$9.7M	Hold	94,000	–	–	0.53%	54
2021 Q3	$7.98M	Hold	94,000	–	–	0.46%	63
2021 Q2	$7.84M	Hold	94,000	–	–	0.46%	60
2021 Q1	$7.07M	Hold	94,000	–	–	0.62%	41
2020 Q4	$6.42M	Hold	94,000	–	–	0.56%	40
2020 Q3	$5.49M	Buy	+94,000	New	+$5.85M	0.49%	49
2020 Q1	–	Sell	-92,000	Closed	-$6.83M	–	189
2019 Q4	$6.83M	Buy	+92,000	New	+$6.46M	0.56%	49
2019 Q1	$4.21M	Sell	78,080 -1	-0%	-$62	0.34%	83
2018 Q4	$5.12M	Sell	78,081 -14,919	-16%	-$1.11M	0.45%	59
2018 Q3	$7.32M	Buy	93,000 +32,000	+52%	+$2.29M	0.53%	50
2018 Q2	$3.92M	Buy	61,000 +7,000	+13%	+$461K	0.47%	59
2018 Q1	$3.36M	Buy	54,000 +8,000	+17%	+$574K	0.4%	75
2017 Q4	$3.33M	Hold	46,000	–	–	0.38%	78
2017 Q3	$3.74M	Buy	46,000 +12,000	+35%	+$949K	0.43%	67
2017 Q2	$2.74M	Buy	34,000 +29,000	+580%	+$2.29M	0.5%	55
2017 Q1	$393K	Buy	+5,000	New	+$399K	0.07%	190
2016 Q3	–	Sell	-31,630	Closed	-$3.03M	–	218
2016 Q2	$3.03M	Hold	31,630	–	–	0.75%	40
2016 Q1	$3.28M	Hold	31,630	–	–	0.8%	35
2015 Q4	$3.09M	Sell	31,630 -10,000	-24%	-$979K	0.72%	36
2015 Q3	$4.02M	Hold	41,630	–	–	0.94%	27
2015 Q2	$4.37M	Hold	41,630	–	–	0.97%	28
2015 Q1	$4.3M	Hold	41,630	–	–	0.89%	31
2014 Q4	$4.01M	Hold	41,630	–	–	0.8%	30
2014 Q3	$3.31M	Hold	41,630	–	–	0.65%	42
2014 Q2	$3.14M	Buy	41,630 +18,000	+76%	+$1.36M	0.62%	45
2014 Q1	$1.77M	Hold	23,630	–	–	0.42%	70
2013 Q4	$1.69M	Buy	23,630 +6,200	+36%	+$398K	0.42%	68
2013 Q3	$989K	Sell	17,430 -3,000	-15%	-$179K	0.32%	96
2013 Q2	$1.17M	Buy	+20,430	New	+$1.18M	0.46%	70

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cornerstone Advisors's CVS Position: Q4 2025 in Review

Cornerstone Advisors sold out of CVS Health (CVS) in Q4 2025, closing a stake of 15,700 shares — an estimated $1.18M sold.

Cornerstone Advisors first reported a position in CVS in Q2 2013 and held it in 42 quarters. The position peaked at $14.8M in Q3 2022. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

Cornerstone Advisors reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
Cornerstone Advisors sold 15,700 CVS Health shares in Q4 2025, an estimated $1.18M.
Cornerstone Advisors first reported a position in CVS Health in Q2 2013 and held it in 42 quarters.
Cornerstone Advisors's CVS Health position peaked at $14.8M in Q3 2022.
1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Cornerstone Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.